Abstract:Abstract Background and aims: Inflammatory microenvironment plays a critical role in promoting hepatocellular carcinoma (HCC) progression. Among the factors secreted by cancer-associated inflammatory cells, tumor necrosis factor-alpha (TNF-α) has been identified as a master regulator of inflammation and a potential mediator in inflammation-related cancers. Forkhead box M1 (FoxM1) is a key cell cycle regulator of the transition from the G1 to the S phase and the progression to mitosis. We previously reported that FoxM1 promotes metastasis and indicates poor prognosis in HCC. However, the critical regulatory mechanism linking TNF-α to FoxM1 activation in inflammation-induced HCC progression remains unclear. In this study, we aim to investigate the mechanism by which FoxM1 is regulated by TNF-α, and the potential role of FoxM1 in inflammation-associated HCC. Methods: Luciferase reporter, chromatin immunoprecipitation, and electrophoretic mobility shift assays were used to measure the transcriptional regulation of FoxM1 promoter by TNF-α. The clinical significance of TNF-α/ROS/HIF-1/FoxM1 pathway in a cohort of 406 HCC patients who underwent curative resection was assessed by Kaplan-Meier analysis and Multivariate Cox proportional hazards model. Results: TNF-α induced FoxM1 expression and transactivated its promoter activity in hepatoma cells. Serial 5′ deletion and site-directed mutagenesis revealed that the induction of FoxM1 expression by TNF-α was dependent upon the HIF1-1 and HIF1-3/4 binding sites within the FoxM1 promoter. Furthermore, at the transcriptional level, the stabilization of HIF-1α via reactive oxygen species (ROS) generation led to the binding of HIF-1α to the FoxM1 promoter and resulted in increased FoxM1 expression. The inhibition of both HIF-1α expression and ROS generation significantly decreased TNF-α-induced FoxM1 expression. Consequently, the upregulation of FoxM1 promoted the proliferation of hepatoma cells and enhanced their resistance to TNF-α-induced apoptosis, whereas downregulation of FoxM1 dramatically attenuated these effects. TNF-α expression was positively correlated with HIF-1α and FoxM1 expression in human HCC tissues. Patients with positive coexpression of TNF-α and FoxM1 had shorter overall survival and higher recurrence rates than those with negative coexpression of TNF-α and FoxM1. Simarily, patients with HIF-1(+)/FoxM1(+) expression had shorter overall survival and higher recurrence rates than those with HIF-1(-)/FoxM1(-) expression. Conclusions: We report a new molecular mechanism by which FoxM1 expression is regulated by the TNF-α/ROS/HIF-1 pathway, and this mechanism results in the proliferation of hepatoma cells and their resistance to apoptosis. Thus, TNF-α/ROS/HIF-1/FoxM1 pathway may provide a target for clinical intervention in HCC. Citation Format: Limin Xia, Daiming Fan, Yongzhan Nie, Kaichun Wu. The TNF-α/ROS/HIF-1-mediated upregulation of FoxM1 expression promotes proliferation, resistance to apoptosis and indicates poor prognosis in hepatocellular carcinoma. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 2862. doi:10.1158/1538-7445.AM2013-2862 Note: This abstract was not presented at the AACR Annual Meeting 2013 because the presenter was unable to attend.

Inflammatory factor TNF-α promotes the growth of breast cancer via the positive feedback loop of TNFR1/NF-κB (and/or p38)/p-STAT3/HBXIP/TNFR1

The Oncoprotein HBXIP Upregulates PDGFB Via Activating Transcription Factor Sp1 to Promote the Proliferation of Breast Cancer Cells

The Oncoprotein HBXIP Upregulates Lin28B Via Activating TF II D to Promote Proliferation of Breast Cancer Cells.

Distinct Role of Interleukin-6 and Tumor Necrosis Factor Receptor-1 in Oval Cell- Mediated Liver Regeneration and Inflammation-Associated Hepatocarcinogenesis

The Oncoprotein HBXIP Uses Two Pathways to Up-regulate S100A4 in Promotion of Growth and Migration of Breast Cancer Cells

TNF-alpha promotes cell cycle progression by activating NF-kappa B signal pathway in hepatic cell line L-02

Tumor necrosis factor receptor signaling modulates carcinogenesis in a mouse model of breast cancer

The Oncoprotein Hbxip Enhances Angiogenesis And Growth Of Breast Cancer Through Modulating Fgf8 And Vegf

Tumor Necrosis Factor-Α Promotes Hepatocellular Carcinogenesis Through the Activation of Hepatic Progenitor Cells.

TNF-α sensitizes chemotherapy and radiotherapy against breast cancer cells

Tumor Necrosis Factor- α Promotes the Tumorigenesis, Lymphangiogenesis, and Lymphatic Metastasis in Cervical Cancer via Activating VEGFC-Mediated AKT and ERK Pathways

TNFRSF9 Suppressed the Progression of Breast Cancer via the p38MAPK/PAX6 Signaling Pathway

The Oncoprotein HBXIP Up-Regulates FGF4 Through Activating Transcriptional Factor Sp1 to Promote the Migration of Breast Cancer Cells.

Tumor Necrosis Factor Α-Induced Protein 1 As a Novel Tumor Suppressor Through Selective Downregulation of CSNK2B Blocks Nuclear Factor-Κb Activation in Hepatocellular Carcinoma.

The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis.

Abstract 2862: The TNF-α/ROS/HIF-1-mediated upregulation of FoxM1 expression promotes proliferation, resistance to apoptosis and indicates poor prognosis in hepatocellular carcinoma.

Kinectin 1 promotes the growth of triple-negative breast cancer via directly co-activating NF-kappaB/p65 and enhancing its transcriptional activity

Nuclear Receptor NR4A1 Promotes Breast Cancer Invasion and Metastasis by Activating TGF-β Signalling

The Oncoprotein HBXIP Promotes Human Breast Cancer Growth Through Down-Regulating P53 Via Mir-18B/mdm2 and Pakt/mdm2 Pathways

Obesity-associated metabolic inflammation promotes triple-negative breast cancer progression through the interleukin-6/STAT3/pentraxin 3/matrix metalloproteinase 7 axis

The Oncoprotein Hbxip Activates Transcriptional Coregulatory Protein Lmo4 Via Sp1 to Promote Proliferation of Breast Cancer Cells